Choose injectable BPC-157 if: Your target is a tendon, ligament, joint, or muscle injury You need systemic anti-inflammatory or tissue repair effects Speed and reliability of delivery matter You are working within a structured peptide therapy protocol with a licensed provider Choose oral BPC-157 if: Your primary concern is gut health leaky gut, IBD, IBS, gastric ulcers You want high local GI concentrations, not systemic distribution You prefer non-invasive administration for long-term or maintenance use You are combining BPC-157 with another systemic peptide therapy Consider nasal delivery only if: Neurological applications are the clinical focus A licensed provider explicitly recommends it based on your presentation Injection is contraindicated and oral delivery is insufficient Do not choose a delivery method based on convenience alone

STIMULATION OF LIPOLYSIS DURING FASTING Fasting acutely stimulates lipolysis, upregulating the serum concentration of fatty acids and glycerol that act as oxidative substrates to maintain energy requirements for other metabolic tissues
That said, several important safety considerations remain: No FDA approval : BPC-157 is not approved by the U.S
However, patients should be aware of potential side effects and know when to seek medical attention
But even then, it should be understood as an experimental deviation from the standard, not the default
Consult with our team before starting any peptide protocol